pharma · Acute Myeloid Leukemia · Narcolepsy · JAZZ
Jazz Pharmaceuticals Ireland
Jazz Pharmaceuticals Ireland Limited
Jazz Pharmaceuticals Ireland clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Waterloo Exchange, Waterloo Road, Dublin, 4, IE
- Founded
- 2003
- Employees
- 3,631
- Programs
- 10
- Drugs
- 72
- Patents
- 36
Jazz Pharmaceuticals Ireland projects
10 ClinicalTrials.gov programs sponsored by Jazz Pharmaceuticals Ireland.
Jazz Pharmaceuticals Ireland has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Sodium Oxybate
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
1 trial -
Xyrem®
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
2 trials -
placebo
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
1 trial -
Defibrotide
Jazz Pharmaceuticals Ireland Limited
DLBCL
1 trial -
Dordaviprone (ONC201)
Jazz Pharmaceuticals Ireland Limited
Glioma
1 trial -
Dordaviprone (ONC201)
Jazz Pharmaceuticals Ireland Limited
Glioblastoma
1 trial -
GWP42003-P
Jazz Pharmaceuticals Ireland Limited
Schizophrenia
1 trial -
Nabiximols
Jazz Pharmaceuticals Ireland Limited
Glioblastoma
1 trial -
Sodium Oxybate
Jazz Pharmaceuticals Ireland Limited
Schizophrenia
1 trial -
Xyrem (sodium oxybate) oral solution
Jazz Pharmaceuticals Ireland Limited
Fibromyalgia
1 trial
Frequently asked questions
How many clinical projects does Jazz Pharmaceuticals Ireland have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.